The Phillips McDougall study, just released by CropLife International, highlights the extensive cost and time involved in getting new biotech crop innovations to market.  

The study draws further attention to the need for a streamlined GMO approval/regulatory process so we can continue to introduce new innovative crop technologies to the market and remain competitive globally as a nation.  According to the study, the cost of discovery, development and authorization of a new plant biotechnology trait introduced between 2008 and 2012 costs an estimated $136 million!  Read the study here.